Barclays
HSCS icon

Barclays’s Heart Test Laboratories HSCS Stock Holding History

Barclays’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+1
New +$3 ﹤0.01% 5255

Other funds holding HSCS

TFB Advisors
TFB Advisors Overland Park, Kansas $245M AUM 19.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Barclays's HSCS Position: Q3 2026 in Review

Barclays opened a new position in Heart Test Laboratories (HSCS) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #5255 among its holdings.

6 funds tracked by Wall St. Rank hold HSCS as of Q3 2026.

  • Barclays held 1 share of Heart Test Laboratories worth $4 as of Q3 2026.
  • Heart Test Laboratories was a new Barclays position in Q3 2026.
  • Heart Test Laboratories made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5255 holding.
  • 6 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.